SCHEMBL14082171

SCHEMBL14082171

COc1c(Br)cc(/C=N/NC(=O)CNc2ccc(Cl)cc2)c(O)c1Br

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.56
▸ SIRT1 Q96EB6 4/20 0.53
▸ MAPT P10636 5/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ ERCC1 P07992 1/20 0.51
▸ ERCC4 Q92889 1/20 0.51
▸ GRK2 P25098 4/20 0.50
▸ ROCK2 O75116 2/20 0.50
▸ ALDH1A1 P00352 3/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ GAA P10253 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ LIG1 P18858 2/20 0.43
▸ LIG3 P49916 1/20 0.43
▸ GRK5 P34947 1/20 0.43
▸ GRK3 P35626 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12872563 0.91 MAPT (0.52) CFTRSIRT1MAPTSMN1; SMN2ERCC1
SCHEMBL14082231 0.89 CFTR (0.59) CFTRSIRT1MAPTERCC1ERCC4
SCHEMBL12648538 0.87 CFTR (0.71) CFTRSIRT1MAPTERCC1ERCC4
SCHEMBL12648525 0.85 CFTR (0.78) CFTRSIRT1MAPTSMN1; SMN2ERCC1
SCHEMBL14082227 0.80 CFTR (0.64) CFTRSIRT1MAPTERCC1ERCC4
SCHEMBL12648542 0.79 CFTR (0.72) CFTRSIRT1MAPTERCC1ERCC4
SCHEMBL18378408 0.79 CFTR (0.72) CFTRSIRT1MAPTERCC1ERCC4
SCHEMBL690273 0.78 GRK2 (0.65) CFTRMAPTERCC1ERCC4GRK2
SCHEMBL690272 0.78 GRK2 (0.65) CFTRMAPTERCC1ERCC4GRK2
SCHEMBL14082228 0.75 GRK2 (0.63) MAPTERCC1ERCC4GRK2ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
US-7414037-B2 cystic fibrosis transmembrane conductance regulator protein inhibitor; 2-naphthalenylamino-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene][3-[4-(3-(PEG)n-thioureido)diphenyl)-thioureido]propanedioic acid dihydrazide (MalH-(PEG)nB); cystic fibrosis with forms of male infertility, secretory diarrhea THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-08-19 — — US disclosed
Send feedback